Inovio Pharmaceuticals, Inc.(INO)- NASDAQ
  • Sun, Aug. 21, 8:56 AM
    • Federal health officials are warning pregnant women and their partners not to travel to Miami Beach after Florida confirmed that the mosquito-borne Zika virus was active in the popular tourist destination.
    • The CDC also suggested that pregnant women who are especially worried about Zika exposure might consider avoiding all of Miami-Dade County.
    • Other fears? In addition to causing the birth defect microcephaly, a new study from Rockefeller University and La Jolla Institute for Allergy and Immunology suggests the virus may cause brain damage in adults as well.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Sun, Aug. 21, 8:56 AM | 41 Comments
  • Sun, Aug. 14, 1:03 PM
    • Three new non-travel cases of the Zika virus have been found in Florida, including another person who doesn't live in the one-square-mile area believed to be the hub of local transmission, bringing the number of cases confirmed there so far to 28.
    • The U.S. Centers for Disease Control and Prevention issued a warning two weeks ago for pregnant women to avoid this area of Miami. Zika has been shown to cause birth defects, including microcephaly, which causes severe developmental problems.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Sun, Aug. 14, 1:03 PM | 24 Comments
  • Fri, Aug. 12, 8:04 AM
    • TeamHealth Holdings (NYSE:TMH) upgraded to Buy from Hold with a $52 (41% upside) price target by Jefferies.
    • Editas Medicine (NASDAQ:EDIT) upgraded to Buy from Hold with a $35 (69% upside) price target by Jefferies.
    • ZIOPHARM Oncology (NASDAQ:ZIOP) upgraded to Market Perform from Underperform by Wells Fargo. Target price range: $5 - 8 (25% upside from midpoint).
    • Bellicum Pharmaceuticals (NASDAQ:BLCM) upgraded to Buy from Neutral with a $24 (22% upside) price target by Citigroup.
    • Alere (NYSE:ALR) upgraded to Buy from Neutral with a $48 (20% upside) price target by BTIG Research.
    • Merck (NYSE:MRK) upgraded to Outperform from Neutral by Credit Suisse. Price target raised to $73 (15% upside) from $62. Upgraded to Outperform from Market Perform by BMO Capital. Price target raised to $72 (13% upside) from $62.
    • Celgene (NASDAQ:CELG) upgraded to Buy from Neutral with a $138 (21% upside) price target by BTIG Research.
    • Bristol-Myers Squibb (NYSE:BMY) downgraded to Hold from Buy by Berenberg. Price target lowered to $70 (15% upside) from $80. Downgraded to Neutral from Outperform by Credit Suisse. Price target lowered to $63 (3% upside) from $86.
    • Zosano Pharma (NASDAQ:ZSAN) downgraded to Neutral from Buy by Ladenburg Thalmann.
    • Myriad Genetics (NASDAQ:MYGN) downgraded to Hold from Buy by Gabelli & Co. Price target lowered to $32 (54% upside) from $46.
    • Ohr Pharmaceutical (NASDAQ:OHRP) downgraded to Hold from Buy by Brean Capital.
    • Inovio Pharmaceuticals (NASDAQ:INO) downgraded to Hold from Buy by Maxim Group. $14 price target removed.
    • Raptor Pharmaceutical (NASDAQ:RPTP) downgraded to Neutral from Buy by Citigroup. Price target raised to $8 (19% upside) from $6.
    • Regeneron Pharmaceuticals (NASDAQ:REGN) downgraded to Neutral from Outperform by Baird. Price target lowered to $488 (16% upside) from $505.
    | Fri, Aug. 12, 8:04 AM | 7 Comments
  • Fri, Aug. 12, 4:38 AM
    • The Obama administration will transfer a total of $81M within the Department of Health and Human Services to work on Zika vaccines amid an increase in cases in the United States.
    • The money is intended to keep research going despite the lack of funding from U.S. lawmakers, who left for summer recess before allocating funds to halt the spread of the virus.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Fri, Aug. 12, 4:38 AM | 23 Comments
  • Mon, Aug. 8, 9:15 AM
    • Inovio Pharmaceuticals (INO) Q2 results: Revenues: $6.2M (+17.0%); Operating Loss: ($18.2M) (-20.5%); Net Loss: ($18.7M) (-201.6%); Loss Per share: ($0.26) (-188.9%); Quick Assets: $134.5M (-17.5%).
    • No guidance given.
    | Mon, Aug. 8, 9:15 AM
  • Mon, Aug. 8, 8:02 AM
    • Inovio Pharmaceuticals (NASDAQ:INO): Q2 EPS of -$0.26 misses by $0.05.
    • Revenue of $6.2M (+17.2% Y/Y) beats by $1.25M.
    • Shares +3.05% PM.
    • Press Release
    | Mon, Aug. 8, 8:02 AM
  • Sun, Aug. 7, 12:40 PM
    • As fears mount about the impacts of Zika, Canaccord's Tony Dwyer is warning that the health crisis (compounded with Italian bank issues, a more hawkish Fed and energy price weakness) could morph into the Ebola scare that enveloped the market two years ago.
    • The S&P 500 slipped 1.7% off its peak once the first U.S. Ebola case was reported in September 2014, and by the time the third American case was diagnosed, the market was already down 7%.
    • "Obviously, no two situations are exactly alike, but this is pretty close," concluded Dwyer. "I'm not looking for anything like a 10% decline... but this could be the catalyst we've been looking for."
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Sun, Aug. 7, 12:40 PM | 58 Comments
  • Thu, Aug. 4, 5:01 AM
    • U.S. government researchers have begun their first clinical trial of a Zika vaccine while the Obama administration told lawmakers funds to fight the virus would run out in the coming weeks due to congressional inaction.
    • The number of locally spread Zika cases has jumped to 15 in Florida and the amount of U.S. states affected has reached 45. As of July 27, 1,658 travel associated cases of Zika were reported across the continental U.S. and Hawaii.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Thu, Aug. 4, 5:01 AM | 21 Comments
  • Wed, Aug. 3, 9:15 AM
    | Wed, Aug. 3, 9:15 AM | 14 Comments
  • Tue, Aug. 2, 9:17 AM
    | Tue, Aug. 2, 9:17 AM | 3 Comments
  • Tue, Aug. 2, 2:38 AM
    • Federal health officials have advised pregnant women to avoid a Miami neighborhood - marking the first time the CDC has warned against travel to any area within the continental U.S. - as a Zika outbreak led to 10 more local cases.
    • Other troubling news... Director Tom Frieden said that extensive spraying of insecticides in the area over the past several weeks has not reduced the local population of mosquitoes capable of transmitting the virus.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Tue, Aug. 2, 2:38 AM | 38 Comments
  • Fri, Jul. 29, 10:07 AM
    • Health officials in Florida confirm that the state is the first in the U.S. to have local cases of transmission of the Zika virus.
    • Four individuals with the illness had not traveled to Zika-infected areas or had any other direct exposure to the virus.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX.
    | Fri, Jul. 29, 10:07 AM | 32 Comments
  • Fri, Jul. 22, 5:00 AM
    • Health officials are investigating a second possible non-travel related case of Zika infection in Florida. To date, there are 334 cases of Zika in the state, including 46 pregnant women.
    • More alarms? Brazilian scientists have found a second species, Culex quinquefasciatus, which can transmit the virus. Culex mosquitoes are far more common in temperate zones, such as in the United States.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Fri, Jul. 22, 5:00 AM | 32 Comments
  • Wed, Jul. 20, 4:44 AM
    • Florida health officials are investigating a possible case of Zika that wasn't carried back by a traveler.
    • If it's confirmed, it would be the first evidence the virus has spread to mosquitoes in the continental U.S.
    • All 1,306 American cases up to now have been in people who traveled to Zika-affected regions or their sexual partners.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Wed, Jul. 20, 4:44 AM | 21 Comments
  • Sun, Jul. 17, 4:55 AM
    • The first case of female-to-male sexual transmission of the Zika virus has been documented in NYC, raising the prospect that the disease will spread further than previously thought.
    • "The more we learn about Zika, the more concerned we are," said Dr. Thomas Frieden, director of the CDC.
    • For months, there has been growing fear about the dangers of sexual transmission, but until now the virus has been thought to pass only from men to women or between two men.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Sun, Jul. 17, 4:55 AM | 62 Comments
  • Thu, Jul. 14, 4:58 AM
    • The failure of Congress to approve any money to help fight Zika is "simply inexcusable" and a "dereliction of duty," senators said during a hearing on Wednesday, just two days before a long break that could mean no money before autumn.
    • Statistics: Almost 600 cases have been reported among pregnant women in the U.S., with seven infants being born with microcephaly, the disturbing birth defect that's become the hallmark of the Zika virus infection.
    • Related tickers: SNY, INO, AEMD, XON, CEMI, BCRX, TMO, OTCQB:GOVX
    | Thu, Jul. 14, 4:58 AM | 30 Comments
Company Description
Inovio Pharmaceuticals, Inc. is a bio-pharmaceutical company, which develops active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies include SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States